Actively Recruiting
Liver Embolization Approaches for Tumor Management
Led by IRCCS San Raffaele · Updated on 2024-04-12
580
Participants Needed
1
Research Sites
553 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this evaluate short, medium and long term outcome of the different embolization techniques in patients with primary and secondary hepatic tumors. The main aim is to evaluate progression free survival following embolization in this study population or evaluate residual hepatic volume in cases in which these techniques are used to induce liver regeneration. This study is an observational registry - all patients will follow their normal therapeutic and treatment scheme as per clinical practice, without any additional intervention.
CONDITIONS
Official Title
Liver Embolization Approaches for Tumor Management
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Patients with primary or secondary liver disease not suitable for surgery or ablation
- Patients with primary or secondary liver tumors who are candidates for major surgery prior to liver hypertrophy induction
- Able and willing to sign informed consent
You will not qualify if you...
- Pregnant women
- Patients with uncorrectable coagulopathy
- Diffuse extrahepatic disease
- Presence of bilodigestive shunt for lobar TACE and TARE
- Hepatopulmonary shunt greater than 20% for TARE
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Ospedale San Raffaele
Milan, Italy, 20132
Actively Recruiting
Research Team
F
Francesco De Cobelli, MD
CONTACT
S
Stephanie Steidler, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here